Bank Julius Baer & Co’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.23M | Sell |
28,489
-5,685
| -17% | -$1.24M | 0.02% | 220 |
|
|
2025
Q1 | $7.69M | Sell |
34,174
-1,810
| -5% | -$407K | 0.03% | 211 |
|
|
2024
Q4 | $11.9M | Buy |
35,984
+4,483
| +14% | +$1.49M | 0.04% | 192 |
|
|
2024
Q3 | $9.59M | Buy |
+31,501
| New | +$9.59M | 0.03% | 191 |
|
|
2024
Q2 | – | Sell |
-19,623
| Closed | -$7.75M | – | 558 |
|
|
2024
Q1 | $7.75M | Sell |
19,623
-594
| -3% | -$234K | 0.03% | 183 |
|
|
2023
Q4 | $7.12M | Buy |
+20,217
| New | +$7.12M | 0.03% | 192 |
|
|
2023
Q2 | – | Sell |
-3,681
| Closed | -$1.28M | – | 610 |
|
|
2023
Q1 | $1.28M | Sell |
3,681
-1,368
| -27% | -$474K | 0.01% | 243 |
|
|
2022
Q4 | $1.19M | Sell |
5,049
-100
| -2% | -$23.5K | 0.01% | 243 |
|
|
2022
Q3 | $1.27M | Buy |
5,149
+642
| +14% | +$158K | 0.01% | 228 |
|
|
2022
Q2 | $1.36M | Buy |
4,507
+4,150
| +1,162% | +$1.26M | 0.01% | 242 |
|
|
2022
Q1 | $147K | Hold |
357
| – | – | ﹤0.01% | 456 |
|
|
2021
Q4 | $167K | Sell |
357
-110
| -24% | -$51.5K | ﹤0.01% | 550 |
|
|
2021
Q3 | $198K | Sell |
467
-73
| -14% | -$31K | ﹤0.01% | 542 |
|
|
2021
Q2 | $194K | Sell |
540
-1,561
| -74% | -$561K | ﹤0.01% | 564 |
|
|
2021
Q1 | $592K | Buy |
2,101
+1,289
| +159% | +$363K | ﹤0.01% | 419 |
|
|
2020
Q4 | $230K | Sell |
812
-45
| -5% | -$12.7K | ﹤0.01% | 547 |
|
|
2020
Q3 | $236K | Sell |
857
-35
| -4% | -$9.64K | ﹤0.01% | 481 |
|
|
2020
Q2 | $203K | Buy |
+892
| New | +$203K | ﹤0.01% | 450 |
|